Kinnate Biopharma Inc. (KNTE) has 11 open-market insider trades by 7 insiders since 2020. The most active filer is Carl L. Gordon, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Carl L. Gordon | Dir10% Owner | — | 4 | $31.8M | 2024-04-03 |
| James B. Tananbaum | Dir10% Owner | — | 2 | $30.0M | 2024-04-03 |
| Foresite Capital Management IV, LLC | 10% Owner | — | 1 | $5.0M | 2023-05-08 |
| Orbimed Advisors LLC | Dir10% Owner | — | 1 | $3.9M | 2023-05-05 |
| OrbiMed Capital GP VII LLC | Dir10% Owner | — | 1 | $3.5M | 2023-05-02 |
| Richard Thomas Williams | — | — | 1 | $678K | 2024-03-01 |
| OrbiMed Genesis GP LLC | Dir | — | 1 | $90K | 2023-02-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| James B. Tananbaum | Director & 10% Owner | Buy | $10.0M | 2023-05-08 |
| Foresite Capital Management IV, LLC | 10% | Buy | $5.0M | 2023-05-08 |
| Carl L. Gordon | Director & 10% Owner | Buy | $7.7M | 2023-05-04 |
| Orbimed Advisors LLC | Director & 10% | Buy | $3.9M | 2023-05-04 |
| OrbiMed Capital GP VII LLC | Director & 10% | Buy | $3.5M | 2023-04-28 |
| Carl L. Gordon | Director & 10% Owner | Buy | $7.0M |
Companies that share insiders with KNTE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-04-28 |
| Richard Thomas Williams | — | Buy | $678K | 2022-03-11 |
| OrbiMed Genesis GP LLC | Director | Buy | $90K | 2022-02-15 |
| Carl L. Gordon | Director | Buy | $2.1M | 2022-02-11 |
| James B. Tananbaum | Director & 10% Owner | Buy | $20.0M | 2020-12-03 |
| Carl L. Gordon | Director & 10% Owner | Buy | $15.0M | 2020-12-02 |